Long-lasting neurotoxic effects of exposure to methylmercury during development

Journal of Internal Medicine

Volumn 273, Issue 5, 2013, Pages 490-497

  Ceccatelli, S ^a   Bose, R ^a   Edoff, K ^a   Onishchenko, N ^a   Spulber, S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Behaviour; Depression; Differentiation; Methylmercury; Neural stem cells; Neurodevelopment

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; METHYLMERCURY;

ARTICLE; CELL AGING; CELL PROLIFERATION; DENTATE GYRUS; DEPRESSION; DNA METHYLATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CELL AGING; CELL PROLIFERATION; DEPRESSION; DISEASE MODELS, ANIMAL; DNA METHYLATION; EVIDENCE-BASED MEDICINE; FEMALE; FLUOXETINE; MALE; METHYLMERCURY COMPOUNDS; MICE; NEURAL STEM CELLS; NEURONS; NEUROTOXICITY SYNDROMES; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TREATMENT OUTCOME;

EID: 84876721920     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12045     Document Type: Article

References (74)

1. Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006; 368: 2167-78.
2. Morel F, Kraepiel A, Amyot M. The chemical cycle and bioaccumulation of mercury. Annu Rev Ecol Syst 1998; 29: 546-66.
3. Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110(Suppl 1): 11-23.
4. Aschner M, Aschner JL. Mercury neurotoxicity: mechanisms of blood-brain barrier transport. Neurosci Biobehav Rev 1990; 14: 169-76.
5. Kerper LE, Ballatori N, Clarkson TW. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol 1992; 262: R761-5.
6. Mottet NK, Vahter ME, Charleston JS, Friberg LT. Metabolism of methylmercury in the brain and its toxicological significance. Met Ions Biol Syst 1997; 34: 371-403.
7. Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, Burbacher T. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 1994; 124: 221-9.
8. Nordenhäll K, Dock L, Vahter M. Cross-fostering study of methyl mercury retention, demethylation and excretion in the neonatal hamster. Pharmacol Toxicol 1998; 82: 132-6.
9. Grandjean P, Jørgensen PJ, Weihe P. Human milk as a source of methylmercury exposure in infants. Environ Health Perspect 1994; 102: 74-7.
10. Oskarsson A, Schültz A, Skerfving S, Hallén IP, Ohlin B, Lagerkvist BJ. Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 1996; 51: 234-41.
11. Stern AH, Smith AE. An assessment of the cord blood: maternal blood methylmercury ratio: implications for risk assessment. Environ Health Perspect 2003; 111: 1465-70.
12. Vahter M, Akesson A, Lind B, Björs U, Schütz A, Berglund M. Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res 2000; 84: 186-94.
13. Skerfving S. Mercury in fish-some toxicological considerations. Food Cosmet Toxicol 1972; 10: 545-56.
14. Takeuchi T. Human effects of methyl mercury as an environmental neurotoxicant. In: Blum K, Manzo L, eds. Neurotoxicology New York: Marcel Dekker, 1985: 345-67.
15. Tsubaki T, Takahashi H eds. Recent Advances in Minamata Disease Studies - Methylmercury Poisoning in Minamata and Niigata, Tokyo: Kodansha, 1986.
16. Watanabe C, Satoh H. Evolution of our understanding of methylmercury as a health threat. Environ Health Perspect 1996; 104(Suppl 2): 367-79.
17. Harada Y, Miyamoto Y, Nonaka I, Ohta S, Ninomiya T. Electroencephalographic studies of Minamata disease in children. Dev Med Child Neurol 1968; 10: 257-8.
18. Matsumoto H, Koya G, Takeuchi T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol 1965; 24: 563-74.
19. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995; 25: 1-24.
20. National Research Council. Toxicological effects of Methylmercury, Washington DC: National Academy Press, 2000.
21. Clarkson TW. Mercury. Annu Rev Public Health 1983; 4: 375-80.
22. Castoldi AF, Johansson C, Onishchenko N et al. Human developmental neurotoxicity of methylmercury: impact of variables and risk modifiers. Regul Toxicol Pharmacol 2008; 51: 201-14.
23. JECFA. Methylmercury. In: WHO Technical Report Series 922. Evaluation of Certain Food Additives and Contaminants. Report of the 61st Joint FAO/WHO Expert Committee on Food Additives. Geneva: JECFA, 2004; 132-9.
24. Becker W, Darnerud P, Petersson-Grawé K. Risks and benefits of fish consumption (Rapport 12-2007). National Food Administration, Uppsala: Kopieringshuset, 2007.
25. Bellinger DC. Interpreting epidemiologic studies of developmental neurotoxicity: conceptual and analytic issues. Neurotoxicol Teratol 2009; 31: 267-74.
26. Debes F, Budtz-Jørgensen E, Weihe P, White RF, Grandjean P. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol Teratol 2006; 28: 363-75.
27. Yorifuji T, Tsuda T, Inoue S, Takao S, Harada M. Long-term exposure to methylmercury and psychiatric symptoms in residents of Minamata, Japan. Environ Int 2011; 37: 907-13.
28. Ceccatelli S, Aschner M eds. Methylmercury and Neurotoxicity. New York: Springer, 2012.
29. Alvarez-Buylla A, Temple S. Stem cells in the developing and adult nervous system. J Neurobiol 1998; 36: 105-10.
30. Frisén J, Johansson CB, Lothian C, Lendahl U. Central nervous system stem cells in the embryo and adult. Cell Mol Life Sci 1998; 54: 935-45.
31. Gage FH, Ray J, Fisher LJ. Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 1995; 18: 159-92.
32. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124: 319-35.
33. Altman J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 1969; 137: 433-57.
34. Cameron HA, Woolley CS, McEwen BS, Gould E. Differentiation of newly born neurons and glial in the dentate gyrus of the adult rat. Neuroscience 1993; 56: 337-44.
35. Lois C, Alvarez-Buylla A. Long-distance neuronal migration in the adult mammalian brain. Science 1994; 264: 1145-8.
36. Tofighi R, Moors M, Bose R, Ibrahim WNW, Ceccatelli S. Neural stem cells for developmental neurotoxicity studies. Methods Mol Biol 2011; 758: 67-80.
37. Ceccatelli S, Daré E, Moors M. Methylmercury-induced neurotoxicity and apoptosis. Chem Biol Interact 2010; 188: 301-8.
38. Tamm C, Duckworth J, Hermanson O, Ceccatelli S. High susceptibility of neural stem cells to methylmercury toxicity: effects on cell survival and neuronal differentiation. J Neurochem 2006; 97: 69-78.
39. Giménez-Llort L, Ahlbom E, Daré E, Vahter M, Ögren S, Ceccatelli S. Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. Environ Toxicol Pharmacol 2001; 9: 61-70.
40. Grandjean P, Weihe P, White RF, Debes F. Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res 1998; 77: 165-72.
41. McKeown-Eyssen GE, Ruedy J, Neims A. Methyl mercury exposure in northern Quebec. II. Neurologic findings in children. Am J Epidemiol 1983; 118: 470-9.
42. Onishchenko N, Tamm C, Vahter M et al. Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice. Toxicol Sci 2007; 97: 428-37.
43. Rossi AD, Ahlbom E, Ogren SO, Nicotera P, Ceccatelli S. Prenatal exposure to methylmercury alters locomotor activity of male but not female rats. Exp Brain Res 1997; 117: 428-36.
44. Tamm C, Duckworth JK, Hermanson O, Ceccatelli S. Methylmercury inhibits differentiation of rat neural stem cells via Notch signalling. NeuroReport 2008; 19: 339-43.
45. Theunissen PT, Schulpen SHW, van Dartel DAM, Hermsen SAB, van Schooten FJ, Piersma AH. An abbreviated protocol for multilineage neural differentiation of murine embryonic stem cells and its perturbation by methyl mercury. Reprod Toxicol 2010; 29: 383-92.
46. Moors M, Rockel TD, Abel J et al. Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ Health Perspect 2009; 117: 1131-8.
47. Edoff K, Ceccatelli S. Methylmercury and neural stem cells. In: Ceccatelli S, Aschner M, eds. Methylmercury and Neurotoxicity. New York: Springer, 2012; 287-302.
48. Bose R, Moors M, Tofighi R, Cascante A, Hermanson O, Ceccatelli S. Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations. Cell Death Dis 2010; 1: e92.
49. Lapham LW, Cernichiari E, Cox C et al. An analysis of autopsy brain tissue from infants prenatally exposed to methylmercury. Neurotoxicology 1995; 16: 689-704.
50. Stein GH, Drullinger LF, Soulard A, Dulić V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 1999; 19: 2109-17.
51. Faustman EM, Ponce RA, Ou YC, Mendoza MAC, Lewandowski T, Kavanagh T. Investigations of methylmercury-induced alterations in neurogenesis. Environ Health Perspect 2002; 110(Suppl 5): 859-64.
52. Ou YC, Thompson SA, Ponce RA, Schroeder J, Kavanagh TJ, Faustman EM. Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. Toxicol Appl Pharmacol 1999; 157: 203-12.
53. Huang J, Gan Q, Han L et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS ONE 2008; 3: e1710.
54. Subkhankulova T, Zhang X, Leung C, Marino S. Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors. Mol Cell Neurosci 2010; 45: 151-62.
55. Wang Y, Guan Y, Wang F, Huang A, Wang S, Zhang YA. Bmi-1 regulates self-renewal, proliferation and senescence of human fetal neural stem cells in vitro. Neurosci Lett 2010; 476: 74-8.
56. Yadirgi G, Leinster V, Acquati S, Bhagat H, Shakhova O, Marino S. Conditional activation of Bmi1 expression regulates self-renewal, apoptosis, and differentiation of neural stem/progenitor cells in vitro and in vivo. Stem Cells 2011; 29: 700-12.
57. Mori K, Yoshida K, Hoshikawa S et al. Effects of perinatal exposure to low doses of cadmium or methylmercury on thyroid hormone metabolism in metallothionein-deficient mouse neonates. Toxicology 2006; 228: 77-84.
58. Franco JL, Teixeira A, Meotti FC et al. Cerebellar thiol status and motor deficit after lactational exposure to methylmercury. Environ Res 2006; 102: 22-8.
59. Bose R, Onishchenko N, Edoff K, Janson Lang AM, Ceccatelli S. Inherited effects of low-dose exposure to methylmercury in neural stem cells. Toxicol Sci 2012; 130: 383-90.
60. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr 2009; 21: 243-51.
61. Pilsner JR, Lazarus AL, Nam D et al. Mercury-associated DNA hypomethylation in polar bear brains via the Luminometric Methylation Assay: a sensitive method to study epigenetics in wildlife. Mol Ecol 2010; 19: 307-14.
62. Skinner MK, Manikkam M, Guerrero-Bosagna C. Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol 2011; 31: 337-43.
63. So A, Jung J, Lee S, Kim H, Kang K. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs. PLoS ONE 2011; 6: e19503.
64. Ulrey CL, Liu L, Andrews LG, Tollefsbol TO. The impact of metabolism on DNA methylation. Hum Mol Genet 2005; 14 Spec No 1: R139-47.
65. Waly M, Olteanu H, Banerjee R et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal. Mol Psychiatry 2004; 9: 358-70.
66. Bagot RC, Meaney MJ. Epigenetics and the biological basis of gene × environment interactions. J Am Acad Child Adolesc Psychiatry 2010; 49: 752-71.
67. Castrén E, Võikar V, Rantamäki T. Role of neurotrophic factors in depression. Curr Opin Pharmacol 2007; 7: 18-21.
68. Colvis CM, Pollock JD, Goodman RH et al. Epigenetic mechanisms and gene networks in the nervous system. J Neurosci 2005; 25: 10379-89.
69. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
70. Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-67.
71. Onishchenko N, Karpova N, Sabri F, Castrén E, Ceccatelli S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem 2008; 106: 1378-87.
72. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519-25.
73. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007; 10: 1110-5.
74. Quintana H, Butterbaugh GJ, Purnell W, Layman AK. Fluoxetine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents. Child Psychiatry Hum Dev 2007; 37: 241-53.